M.G.L. Hertog

1.9k total citations
11 papers, 1.5k citations indexed

About

M.G.L. Hertog is a scholar working on Biochemistry, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, M.G.L. Hertog has authored 11 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biochemistry, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in M.G.L. Hertog's work include Phytochemicals and Antioxidant Activities (5 papers), Asthma and respiratory diseases (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). M.G.L. Hertog is often cited by papers focused on Phytochemicals and Antioxidant Activities (5 papers), Asthma and respiratory diseases (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). M.G.L. Hertog collaborates with scholars based in Netherlands, United Kingdom and United States. M.G.L. Hertog's co-authors include P.C.H. Hollman, P C Elwood, Daan Kromhout, A M Fehily, P M Sweetnam, Mira Katan, R. Alexandra Goldbohm, H.A.M. Brants, Piet A. van den Brandt and G. van Poppel and has published in prestigious journals such as American Journal of Clinical Nutrition, JNCI Journal of the National Cancer Institute and Biochemical Society Transactions.

In The Last Decade

M.G.L. Hertog

11 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.G.L. Hertog Netherlands 9 842 442 274 248 191 11 1.5k
Janelle M. Landau United States 7 641 0.8× 590 1.3× 231 0.8× 545 2.2× 204 1.1× 10 1.6k
Salka E. Nielsen Denmark 17 651 0.8× 261 0.6× 304 1.1× 468 1.9× 122 0.6× 23 1.5k
Philip C. Morrice United Kingdom 16 482 0.6× 316 0.7× 126 0.5× 283 1.1× 173 0.9× 30 1.4k
Debra A. Pearson United States 12 907 1.1× 215 0.5× 263 1.0× 183 0.7× 381 2.0× 15 1.4k
Julie M. Proudfoot Australia 18 843 1.0× 248 0.6× 273 1.0× 423 1.7× 96 0.5× 23 1.7k
Andreas R. Rechner United Kingdom 16 1.0k 1.2× 469 1.1× 230 0.8× 634 2.6× 352 1.8× 20 2.1k
Derek D. Schramm United States 12 1.0k 1.2× 293 0.7× 167 0.6× 225 0.9× 364 1.9× 14 1.6k
Inge Lise F. Nielsen Switzerland 9 492 0.6× 396 0.9× 199 0.7× 318 1.3× 158 0.8× 11 1.2k
Christian Rémésy France 14 723 0.9× 317 0.7× 280 1.0× 522 2.1× 227 1.2× 19 1.9k
Karen O’Leary United Kingdom 11 805 1.0× 286 0.6× 274 1.0× 672 2.7× 222 1.2× 12 1.7k

Countries citing papers authored by M.G.L. Hertog

Since Specialization
Citations

This map shows the geographic impact of M.G.L. Hertog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G.L. Hertog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G.L. Hertog more than expected).

Fields of papers citing papers by M.G.L. Hertog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.G.L. Hertog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G.L. Hertog. The network helps show where M.G.L. Hertog may publish in the future.

Co-authorship network of co-authors of M.G.L. Hertog

This figure shows the co-authorship network connecting the top 25 collaborators of M.G.L. Hertog. A scholar is included among the top collaborators of M.G.L. Hertog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.G.L. Hertog. M.G.L. Hertog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hirst, Peter H., et al.. (2002). Lung deposition of budesonide from the novel dry powder inhaler AirmaxTM. Respiratory Medicine. 96(6). 389–396. 25 indexed citations
3.
Perrin, V.L., et al.. (2002). Bronchodilating effects of salbutamol from a novel inhaler AirmaxTM. Respiratory Medicine. 96(7). 493–498. 5 indexed citations
4.
Hertog, M.G.L., P M Sweetnam, A M Fehily, P C Elwood, & Daan Kromhout. (1997). Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. American Journal of Clinical Nutrition. 65(5). 1489–1494. 406 indexed citations
5.
Hertog, M.G.L. & Mira Katan. (1997). Quercetin in foods, cardiovascular disease, and cancer.. Socio-Environmental Systems Modeling. 447–467. 21 indexed citations
6.
Goldbohm, R. Alexandra, M.G.L. Hertog, H.A.M. Brants, G. van Poppel, & Piet A. van den Brandt. (1996). Consumption of Black Tea and Cancer Risk: a Prospective Cohort Study. JNCI Journal of the National Cancer Institute. 88(2). 93–100. 188 indexed citations
7.
Hertog, M.G.L. & P.C.H. Hollman. (1996). Potential health effects of the dietary flavonol quercetin.. PubMed. 50(2). 63–71. 262 indexed citations
8.
Hertog, M.G.L., et al.. (1996). Fruit and vegetable consumption and cancer mortality in the Caerphilly Study.. PubMed. 5(9). 673–7. 108 indexed citations
9.
Hollman, P.C.H., M.G.L. Hertog, & Mira Katan. (1996). Role of dietary flavonoids in protection against cancer and coronary heart disease. Biochemical Society Transactions. 24(3). 785–789. 168 indexed citations
10.
Hertog, M.G.L.. (1995). Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Archives of Internal Medicine. 155(4). 381–386. 315 indexed citations
11.
Hertog, M.G.L.. (1995). Antioxidative Flavonoide in der Nahrung: Herzinfarkt- und Karzinomrisiken. Complementary Medicine Research. 2(5). 283–288. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026